Editor(s):

(1) Prof.  John Yahya I. Elshimali, Professor, UCLA School of Medicine & Charles R. Drew University of Medicine and Science, California, USA.

Reviewers:

(1) Orlando J. Castejón, Neuroscience Clinical Institute and Biological Research Institute, Zulia University, Venezuela.

(2) Mostafa Daemi, University of Social Welfare and Rehabilitation Sciences, Iran.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 9/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Orlando J. Castejón, Venezuela) | File 1 | NA

Stage 2 | Peer review report_2 (Mostafa Daemi, Iran) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Takashi Ikeno, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.

Reviewers:

(1) Alan Kelbis Oliveira Lima, University of Brasília, Brazil.

(2) Ashraf ALakkad, Madinat Zayed Hospital, United Arab Emirates.

Additional Reviewers:

(1) Abhay Maurya, Mizoram University, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Alan Kelbis Oliveira Lima, Brazil) | File 1 | NA

Stage 2 | Peer review report_2 (Ashraf ALakkad, United Arab Emirates) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Takashi Ikeno, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.

(2) Dr. Rafik Karaman, Professor, College of Pharmacy, Al-Quds University, Jerusalem, Palestine.

Reviewers:

(1) Omaima Mohamed Elalem, Port Said University, Egypt.

(2) Md Abdur Razzak, Delaware Biotechnology institute, University of Delaware, USA.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Omaima Mohamed Elalem, Egypt) | File 1 | NA

Stage 2 | Peer review report_2 (Md Abdur Razzak, USA) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Stage 3 | Comment_Editor_2_v1 | File 1 | NA

Editor(s):

(1) Dr. Asmaa Fathi Moustafa Hamouda, Assistant Professor,  Jazan University, Saudi Arabia.

Reviewers:

(1) Zahoor Ahmad Sajid, University of the Punjab, Pakistan.

(2) Naga Ravi Kiran Tangirala, Narasaraopeta Institute of Pharmaceutical Sciences, India.

Additional Reviewers:

(1) Ashish Maruti Shendurse, Kamdhenu University, India.

(2) Ifora ifora, School of Pharmaceutical Science, Indonesia.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Zahoor Ahmad Sajid, Pakistan) | File 1 | NA

Stage 2 | Peer review report_2 (Naga Ravi Kiran Tangirala, India) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Stage 3 | Revised_MS_v2_and_Feedback_v2 | File 1 | NA

Editor(s):

(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems Propharmex Company, India.

Reviewers:

(1) Joan-Antoni Valles, UdG, Spain.

(2) Akanksha Tomar, NSCB Medical College Jabalpur, India.

(3) Takahiko Nagamine, Sunlight Brain Research Center, Japan.

Additional Reviewers:

(1) Dominic Worku, United Kingdom.

(2) Dharmendra Panchal, Gujarat University, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Joan-Antoni Valles, Spain) | File 1 | File 2

Stage 2 | Peer review report_2 (Akanksha Tomar, India) | File 1 | NA

Stage 2 | Peer review report_3 (Takahiko Nagamine, Japan) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems Propharmex Company, India.

Reviewers:

(1) Zheng Liu, Peking Medical College, China.

(2) Mahbuba Sharmin, Bangabandhu Sheik Mujib Medical University, Bangladesh.

Additional Reviewers:

(1) Fevzi Cengiz, Tinaztepe University, Turkey.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 9/10

Average Peer review marks at publication stage: 9.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Zheng Liu, China) | File 1 | NA

Stage 2 | Peer review report_2 (Mahbuba Sharmin, Bangladesh) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Giuseppe Murdaca, University of Genoa, Italy.

Reviewers:

(1) Muhammad Miandad, University of Gujrat, Pakistan.

(2) Devaraj Chandrashekar, Chapman University, USA.

Additional Reviewers:

(1) G. Nageswara Rao, Andhra University, India.

(2) Harish M, SCMS Institute of Bioscience & Biotechnology Research & Developement, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Muhammad Miandad, Pakistan) | File 1 | NA

Stage 2 | Peer review report_2 (Devaraj Chandrashekar, USA) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Giuseppe Murdaca, University of Genoa, Italy.

Reviewers:

(1) Rachna Jain, India.

(2) Shaik Mohammed Asif, King Khalid University, Saudi Arabia.

Additional Reviewers:

(1) Maryam Zahed, Shiraz University of Medical Sciences, Iran.

(2) Mohnish Muchhal, Subharti Dental College, India.

(3) Smriti Golhar, VSPMDCRC. MUHS Nashik University, India

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 9/10

Average Peer review marks at publication stage: 9.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Rachna Jain, India) | File 1 | NA

Stage 2 | Peer review report_2 (Shaik Mohammed Asif, Saudi Arabia) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Rafik Karaman, Professor, Al-Quds University, Jerusalem, Palestine.

Reviewers:

(1) Afewerk Getachew, Mekelle University,Ethiopia.

(2) Akinde Kehinde Yemisi, Ekiti State University, Nigeria.

(3) Ilochi Ogadinma, Madonna University, Nigeria.

Additional Reviewers:

(1) Prakash Katakam, Indira College of Pharmacy, India.

(2) Sakina Salem Saadawi, University of Tripoli, Libya.

(3) Abikesh Prasada Kumar Mahapatra, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Afewerk Getachew, Ethiopia) | File 1 | File 2

Stage 2 | Peer review report_2 (Akinde Kehinde Yemisi, Nigeria) | File 1 | File 2

Stage 2 | Peer review report_3 (Ilochi Ogadinma, Nigeria) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Takashi Ikeno, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.

Reviewers:

(1) S. Lokesh, ICMR-National Institute of Epidemiology, India.

(2) D.S.Pushparani, Dg Vaishnav College, India.

(3) Sheikh Shahnawaz, India.

(4) Lucaci Corina, Regina Maria Hospital, Romania.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (S. Lokesh, India) | File 1 | NA

Stage 2 | Peer review report_2 (D.S.Pushparani, India) | File 1 | File 2

Stage 2 | Peer review report_3 (Sheikh Shahnawaz, India) | File 1 | NA

Stage 2 | Peer review report_4 (Lucaci Corina, Romania) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Stage 3 | Comment_Editor_2_v1 | File 1 | NA